advertisement
Xing X 9
Showing records 1 to 9 | Display all abstracts from Xing X106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Sun X
Ophthalmology and therapy 2023; 12: 341-353
106140 Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
Hao H; He B
Biomaterials advances 2022; 142: 213162
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Yao K
Ophthalmology and therapy 2023; 12: 341-353
106140 Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
Yu B
Biomaterials advances 2022; 142: 213162
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Liu Q; Zhang H
Ophthalmology and therapy 2023; 12: 341-353
106140 Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
Yang J
Biomaterials advances 2022; 142: 213162
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Xing X
Ophthalmology and therapy 2023; 12: 341-353
106140 Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
Xing X; Liu W
Biomaterials advances 2022; 142: 213162
106340 Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Fang A; Duan X; Yu M; Chen MY; Yang J; Goodkin ML
Ophthalmology and therapy 2023; 12: 341-353
